from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3837c/-

LFCtreatmentdescriptionclass of inhibitor

-1.157

Amikacinug/mL Amikacintranslation

-1.295

Cap5-10ug/mL Capreomycintranslation

-1.749

Rox10-50 ug/mL Roxithromycintranslation

0.353

SM2-5 ug/mL Streptomycintranslation

-0.018

Tet5-10 ug/mL Tetracyclinetranslation

-0.307

Rif0.2-5ug/mL Rifampicintranscription

0.010

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.646

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.853

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.090

CPZ10-50 ug/mL Chlorpromazinerespiration

1.857

Clofazimine10-13 ug/mL Clofaziminerespiration

0.415

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.142

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.367

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.602

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.691

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.075

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.149

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.323

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.978

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.207

KCN5-20 ug/mL Potassium cyaniderespiration

-0.133

NaN30.2-2 mM Sodium aziderespiration

0.137

Nigericin50 uM Nigericinrespiration

-0.154

TRC10-150 ug/mL Triclosanrespiration

3.901

TRZ10-25 ug/mL Thioridazinerespiration

0.531

Valinomycin0.5-10 uM Valinomycinrespiration

0.025

ZnSO42 mM ZnSO4respiration

0.713

menadione6-10 ug/mL Menadionerespiration

0.903

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.461

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.190

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.224

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.283

NRP_1Non-replicating persistence stage 1dosRassociated

-0.056

Amp0.2mg/mL AmpicillincellWall

-0.229

Cephalexin20-100 ug/mL CephalexincellWall

-0.081

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.578

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.129

EMB10-20 ug/mL EthambutolcellWall

0.070

Eta12-40 ug/mL EthionamidecellWall

0.366

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.064

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.086

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.684

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.635

BZA0.12 mg/mL BenzamidearomaticAmides

-0.912

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.381

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.056

H2O24 mM hydrogen peroxideDNAdamaging

-0.218

Levo10 ug/mL LevofloxacinDNAdamaging

-0.538

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.710

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.158

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.306

UVUV-irradiationDNAdamaging

1.526

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.129

Antimycin12.5-50 ug/mL Antimycin A?

-0.088

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.343

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.137

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.635

PA8240.2-2 ug/mL PA-824?

-0.031

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.055

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.202

Verapamil50 uM Verapamil?

-0.733

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.157

methoxatin10-20 ug/mL Methoxatin?